Brain News and Research

RSS

The human brain is the center of the human nervous system and is a highly complex organ. Enclosed in the cranium, it has the same general structure as the brains of other mammals, but is over three times as large as the brain of a typical mammal with an equivalent body size.

Study demonstrates efficacy of CONCERTA in treating ADHD in presence of comorbid learning disability

Turning in assignments, following instructions and focusing on learning something new are among the daily classroom challenges for children with Attention Deficit Hyperactivity Disorder (ADHD), according to the National Institute of Mental Health (NIMH). New data presented today show efficacy of CONCERTA® (OROS® methylphenidate HCl Extended-Release Tablets CII) on ADHD symptoms in children with the condition who also may face other specific challenges.

26 May 2010

UCSF scientists discover new stem cell in developing human brain

UCSF scientists have discovered a new stem cell in the developing human brain. The cell produces nerve cells that help form the neocortex - the site of higher cognitive function -- and likely accounts for the dramatic expansion of the region in the lineages that lead to man, the researchers say.

26 May 2010

Highlights from June 2010 issue of American Journal of Pathology

Dr. Kanneboyina Nagaraju and colleagues at the Children's National Medical Center, Washington, DC demonstrate that affected muscle may directly contribute to inflammation in muscular dystrophy. Their report can be found in the June 2010 issue of The American Journal of Pathology.

26 May 2010

Researchers use CASL MRI technique to map cerebral blood flow patterns in schizophrenic patients

Researchers in Germany have used a magnetic resonance imaging technique called continuous arterial spin labeling to map cerebral blood flow patterns in schizophrenic patients quickly and without using radiation or contrast agents. Their findings appear in the online edition and July printed issue of the journal Radiology.

26 May 2010

Increasing levels of GGA3 protein prevent accumulation of enzyme linked to Alzheimer's disease

Researchers at Tufts University School of Medicine have zeroed in on a protein that may play a role in the progression of Alzheimer's disease. The team found that increasing levels of the protein (called GGA3) prevented the accumulation of an enzyme linked to Alzheimer's. The strategy may lead to new treatments for the neurodegenerative disease.

26 May 2010

Targeted enrollment in Phase IIb trial for EpiCept NP-1 in CPN attained: EpiCept

EpiCept Corporation today announced that the targeted enrollment in a Phase IIb trial for EpiCept NP-1 in chemotherapy-induced peripheral neuropathy has been attained. The trial is being conducted by National Cancer Institute -funded Community Clinical Oncology Program.

26 May 2010

NIDDK awards Albert Einstein College of Medicine $9.5M for continuation of Diabetes Research and Training Center

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine of Yeshiva University a five-year, $9.5 million grant for the continuation of its Diabetes Research and Training Center (DRTC). The DRTC was also awarded a $632,000 supplemental grant for equipment and additional pilot and feasibility studies through the American Recovery and Reinvestment Act (ARRA), bringing total NIH support to $10,177,000.

26 May 2010

Defect in cellular pathways provides new explanation for earliest stages of craniosynostosis in newborns

University of Rochester Medical Center scientists discovered a defect in cellular pathways that provides a new explanation for the earliest stages of abnormal skull development in newborns, known as craniosynostosis.

26 May 2010

New approach to prevention and management of Alzheimer's disease

With the aging of nearly 80 million baby boomers, Alzheimer's disease is an impending epidemic that requires a new approach to prevention as well as management of the disease, according to a UC Santa Barbara professor who has co-authored a new book on the topic.

26 May 2010

Medtronic fiscal year 2010 revenue up 8% to $15.817 billion

Medtronic, Inc. today announced financial results for its fourth quarter and fiscal year ended April 30, 2010.

25 May 2010

FDA grants priority review for Alkermes' VIVITROL sNDA for opioid dependence

Alkermes, Inc. today announced that the supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) for opioid dependence has been designated a priority review by the U.S. Food and Drug Administration (FDA).

25 May 2010

Anaheim Regional Medical Center uses Arctic Sun cooling device to protect a patient from brain damage

A day after delivering her fourth child at Anaheim Regional Medical Center in Anaheim, California last December, 34-year-old Brynn Ervin suffered a cardiac arrest, the result of massive blood clots lodged in the main arteries that take blood to her lungs. Desperate to save the life of the young mother, the cardiac arrest team performed 95 minutes of CPR.

25 May 2010

New campaign to raise awareness about soul wrenching realities of Alzheimer's disease

The Alzheimer Society is launching a new campaign in an effort to raise awareness about the soul wrenching realities of Alzheimer's disease, and the Society's efforts to fund research towards a cure.

25 May 2010

Masimo PVI identifies patients at high risk for developing severe hypotension during anesthesia induction

Masimo, the inventor of Pulse CO-Oximetry and Measure-Through Motion and Low Perfusion pulse oximetry, announced today that a new clinical study published in the May 2010 issue of Acta Anaesthesiologica Scandinavica shows that Masimo pleth variability index can be used to help clinicians assess risk for mean arterial pressure decreases and subsequent hypotension during anesthesia administration.

25 May 2010

Biogen Idec to join global MS community to commemorate the second annual World MS Day

On May 26, Biogen Idec will join the global multiple sclerosis community to commemorate the second annual World MS Day. Biogen Idec is a leader in the fight against MS, bringing hope to the thousands of patients across the globe who benefit from the company's MS therapies and ongoing research programs.

25 May 2010

New $7M I-LABS MEG Brain Imaging Center opened to study infants, young children

The University of Washington Institute for Learning & Brain Sciences announced today the launch of a multi-year, multimillion-dollar initiative to foster new brain research discoveries and insights into how and when children learn. Washington State Governor Christine Gregoire, University of Washington President Mark Emmert and I-LABS co-directors Dr. Patricia Kuhl and Dr. Andrew Meltzoff officially opened the new $7 million I-LABS MEG Brain Imaging Center on the University of Washington campus, hosting the first brain imaging device in the world optimized for neuroscientific study in infants and young children.

From Elekta 25 May 2010

Incidence of pediatric mobility aid-related injuries in the U.S.

Children and adolescents with an injury or disability may use mobility aids such as crutches, walkers and wheelchairs to help them move around more easily. However, use of these aids has been associated with risk for injury.

25 May 2010

Neuralstem updates progress of ongoing Phase I human clinical trial for ALS

Neuralstem, Inc. updated the progress of its ongoing Phase I human clinical trial to treat ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig's disease) at Emory University in Atlanta, Georgia. The company announced that, after reviewing the safety data from the first cohort of three patients, the Safety Monitoring Board has approved moving to the next cohort and transplantation of the fourth patient.

25 May 2010

Combination therapy improves patients with depression symptoms: Study

New data presented today at the American Psychiatric Association's annual meeting suggests a benefit to combining L-methylfolate, a prescription medical food called Deplin, with an antidepressant at the start of treatment. This retrospective analysis showed a significantly greater improvement in depression symptoms in a shorter period of time, when patients with Major Depressive Disorder were started on combination therapy.

25 May 2010

Traumatic brain injuries may disrupt sleep patterns, says study

People with brain injuries may produce low amounts of melatonin, which affects their sleep, according to a study published in the May 25, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology.

25 May 2010

Brain News and Research

Further Reading

Study demonstrates efficacy of CONCERTA in treating ADHD in presence of comorbid learning disability

UCSF scientists discover new stem cell in developing human brain

Highlights from June 2010 issue of American Journal of Pathology

Researchers use CASL MRI technique to map cerebral blood flow patterns in schizophrenic patients

Increasing levels of GGA3 protein prevent accumulation of enzyme linked to Alzheimer's disease

Targeted enrollment in Phase IIb trial for EpiCept NP-1 in CPN attained: EpiCept

NIDDK awards Albert Einstein College of Medicine $9.5M for continuation of Diabetes Research and Training Center

Defect in cellular pathways provides new explanation for earliest stages of craniosynostosis in newborns

New approach to prevention and management of Alzheimer's disease

Medtronic fiscal year 2010 revenue up 8% to $15.817 billion

FDA grants priority review for Alkermes' VIVITROL sNDA for opioid dependence

Anaheim Regional Medical Center uses Arctic Sun cooling device to protect a patient from brain damage

New campaign to raise awareness about soul wrenching realities of Alzheimer's disease

Masimo PVI identifies patients at high risk for developing severe hypotension during anesthesia induction

Biogen Idec to join global MS community to commemorate the second annual World MS Day

New $7M I-LABS MEG Brain Imaging Center opened to study infants, young children

Incidence of pediatric mobility aid-related injuries in the U.S.

Neuralstem updates progress of ongoing Phase I human clinical trial for ALS

Combination therapy improves patients with depression symptoms: Study

Traumatic brain injuries may disrupt sleep patterns, says study

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News